Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Friday 01 April, 2016

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 9532T
GlaxoSmithKline PLC
01 April 2016
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

In accordance with DTR 3.1.4 R(1)(c) GlaxoSmithKline plc (GSK) was advised on 1 April 2016 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 31 March 2016, at a price of $40.55 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:

 

 

 

Connected Person

 

Number of ADSs

 

Dr K Slaoui (Connected Person of Dr M M Slaoui)

 

 

9

 

 

 

V A Whyte

Company Secretary

 

1 April 2016

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZFLFBQZFFBBD

a d v e r t i s e m e n t